#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hereditary angioedema with C1 esterase inhibitor deficiency Huntington's disease Choroid melanoma Oesophageal squamous cell carcinoma stage II Primary immunodeficiency syndrome Leukoencephalopathy Glioblastoma Alveolar proteinosis Acute hepatic failure Becker's muscular dystrophy Haemophilia A without inhibitors Hairy cell leukaemia recurrent Neurodevelopmental disorder Porphyria non-acute Glomerulonephritis membranoproliferative More trials…

    Learn about Rare Diseases

    Mast cell activation syndrome – Diagnostics Factor IX deficiency – Trials in Disease Uterine leiomyosarcoma – Life with Disease Langerhans cell sarcoma – Life with Disease Ocular melanoma Small intestine leiomyosarcoma – Trials in Disease Familial haemophagocytic lymphohistiocytosis Waldenstrom’s macroglobulinaemia refractory – Life with Disease Testicular leiomyosarcoma – Diagnostics Aicardi-Goutieres syndrome – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Cabergoline ANTIMETABOLITES Cendakimab Thiocolchicoside Ranibizumab Topotecan Hydrochloride Diacerein Amiodarone Hydrochloride F770/05 AZD0292 Mometasone Furoate Tilsotolimod Sodium Antipsychotics Sabatolimab ULIXERTINIB Ozanimod Methylprednisolone Acetate Ciclosporin Idecabtagene Vicleucel Efinopegdutide More therapies…

    Learn about Your Condition

    Paraesthesia Pyrexia Nervous system disorder Thymic carcinoma Chorea Eructation Brain neoplasm Gestational diabetes Toxicity to various agents Paedophilia Septic shock Aphthous ulcer Triple negative breast cancer Biliary cancer metastatic Pneumonia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on Ersodetug for Patients with Uncontrolled Low Blood Sugar Due to Tumor-Related High Insulin Levels

    Recruiting

    3 1 1
    Investigated Drugs:
    • Anti-(Insulin Receptor) Human Monoclonal Antibody
    France The Netherlands

  • Study on Tirzepatide for Women with Overweight or Obesity and Polycystic Ovary Syndrome (PCOS)

    Recruiting

    3 1 1
    Investigated Diseases:
    • Polycystic ovarian syndrome
    • Obesity
    • Overweight
    Investigated Drugs:
    • Medroxyprogesterone Acetate
    • Dydrogesterone
    • Glucose
    Germany

  • Study of Temozolomide, Topotecan, Bevacizumab, Irinotecan and Dinutuximab Beta in Patients with High-Risk Relapsed Neuroblastoma

    Recruiting

    1 1 1 1
    Investigated Drugs:
    • Dinutuximab Beta
    • Topotecan
    • Irinotecan
    Austria Belgium Denmark France Germany Italy +4

  • Vusolimogene Oderparepvec with Nivolumab for Advanced Melanoma Patients Whose Cancer Progressed After Previous Immunotherapy Treatments

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Malignant melanoma
    Investigated Drugs:
    • Vusolimogene Oderparepvec
    • Relatlimab
    • Dacarbazine Citrate
    France Germany Greece Italy Poland Spain

  • Effectiveness and Safety of Abrocitinib in Children 6 to Under 12 Years with Moderate-to-Severe Atopic Dermatitis

    Recruiting

    3 1
    Investigated Diseases:
    • Dermatitis atopic
    Investigated Drugs:
    • Abrocitinib
    Germany Hungary Poland Spain

  • Study of Continuous Infusion of Cloxacillin Using Elastomeric Pump in Adult Patients with Staphylococcus Aureus Infection

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Staphylococcal infection
    Investigated Drugs:
    • Cloxacillin Sodium
    Sweden
Previous Page
1 … 173 174 175 176 177 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!